Takeda Pharma has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (M...
Japan-based Kaneka Corporation has released a product that can simultaneously detect COVID-19 - Real-time PCR detection ...
The In Vitro Diagnostics Division of PHC Corporation, a provider of medical devices and diagnostics, has received Europe...
The novel coronavirus (SARS-CoV-2), responsible for the ongoing COVID-19 pandemic, has affected millions of people world...
Japan-based FUJIFILM Corporation and National Center of Neurology and Psychiatry have announced positive study results o...
UK's Engitix, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its propr...
Mitsui, the global network of healthcare organizations driving real-world research to accelerate the development of new ...
Japan-based National University Corporation Osaka University, Shimadzu Corporation, and SIGMAXYZ Inc. have signed an agr...
US' Ardelyx, has reached an agreement with its Japanese collaboration partner, Kyowa Kirin Co. Ltd., to amend the licens...
US-based Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Bi...
Japan's PENTAX Medical, a division of HOYA Group, has announced the appointment of Dr Klaus Mergener to the po...
AGC Inc., a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand ...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...
Japanese pharmaceutical company Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics ca...
French firm Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Japan's Teij...
US' Halozyme Therapeutics has announced a global collaboration and license agreement with Japan's Chugai Pharmaceutical ...
Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...
PENTAX Medical, a division of HOYA Group, has announced the appointment of Rainer Burkard to the position of Global Pres...
